Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2024-03-29 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
年度股东大会通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2023 Annual General Meeting (AGM) of the company 大博医疗科技股份有限公司. It includes information about the meeting date, voting procedures (both in-person and online), agenda items to be discussed and voted on, registration details, and attachments such as proxy forms and voting instructions. The document does not contain the actual annual report, financial statements, or detailed financial data but rather serves as an official announcement and invitation to shareholders to participate in the AGM. The presence of agenda items like the 2023 annual report and financial statements indicates these will be presented or approved at the meeting, but the document itself is not the report. Given the content and length (6059 characters), it is a formal notice of the AGM rather than the report or voting results. Therefore, the appropriate classification is AGM Information (AGM-R).
2024-03-29 Chinese
董事会战略发展委员会议事规则（2024年3月）
Governance Information Classification · 100% confidence The document is titled '董事会战略发展委员会议事规则' which translates to 'Board Strategic Development Committee Meeting Rules'. It outlines the rules, composition, responsibilities, and procedures of a board committee. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, or any other regulatory filings. It is a governance document detailing internal board committee rules and governance practices. Therefore, it fits best under Governance Information (CGR). The document length is 1767 characters, which is consistent with a detailed governance policy document rather than a brief announcement or report publication.
2024-03-29 Chinese
关于公司2023年度拟不进行利润分配的专项说明
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement from a company regarding its 2023 annual profit distribution plan, specifically stating that no dividends or profit distributions will be made. It includes details about the board and supervisory committee meetings, independent directors' opinions, and references the 2023 audit report. The document is relatively short (2004 characters) and primarily serves to inform shareholders and the public about the proposed profit distribution plan and its submission to the upcoming shareholders' meeting for approval. It does not contain full financial statements or comprehensive financial performance data typical of an Annual Report (10-K) or Interim Report (IR). Instead, it is an announcement related to dividend policy and shareholder meeting agenda items. Therefore, the most appropriate classification is Notice of Dividend Amount (DIV), as it concerns the company's dividend distribution decision and related disclosures.
2024-03-29 Chinese
独立董事专门会议工作制度（2024年3月）
Governance Information Classification · 95% confidence The document is a detailed internal governance policy titled '独立董事专门会议工作制度' (Independent Directors Special Meeting Work System) for a company, outlining the rules, procedures, and responsibilities related to independent directors' meetings. It references relevant laws and regulatory guidelines but does not contain financial data, audit results, or shareholder voting outcomes. It is a governance-related document focused on board procedures and director duties rather than a report, announcement, or financial statement. Therefore, it fits best under Governance Information (CGR). The document length is 2845 characters, which is consistent with a policy document rather than a brief announcement or a full report.
2024-03-29 Chinese
董事会议事规则（2024年3月）
Governance Information Classification · 95% confidence The document is titled '董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors' of a company. It details the composition, powers, meeting procedures, voting rules, and responsibilities of the board of directors. It references relevant laws and regulations governing board operations but does not contain financial data, audit results, or report summaries. It is a governance document outlining internal rules and governance practices of the company. Therefore, it fits the category of Governance Information (CGR). The document length is sufficient and it is not an announcement or a brief notice, so it is not a report publication announcement or regulatory filing. Hence, the classification is CGR with high confidence.
2024-03-29 Chinese
关于公司2024年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from a company regarding its expected related party transactions for the fiscal year 2024. It includes detailed descriptions of the types and amounts of transactions anticipated with related parties, references to board and independent director approvals, and compliance with stock exchange listing rules. The document does not contain financial statements or comprehensive financial performance data but rather focuses on the disclosure of related party transactions and their governance. It is not an annual report, interim report, earnings release, or any other financial report type. It is also not a simple announcement of a report publication but a substantive disclosure about related party transactions. This type of document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-03-29 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.